| scholarly article | Q13442814 |
| P2093 | author name string | Pier Paolo Piccaluga | |
| Falko Fend | |||
| Leticia Quintanilla-Martinez | |||
| Lorenzo Leoncini | |||
| Stefano Lazzi | |||
| Teresa Marafioti | |||
| Michele Bibas | |||
| Lucia Mundo | |||
| Ayse U Akarca | |||
| Joshua Nyagol | |||
| Virginia Mancini | |||
| Hasan Rizvi | |||
| Maria Chiara Siciliano | |||
| Massimo Granai | |||
| Noel Onyango | |||
| Ibrahim Maha | |||
| Nicholas Othieno Abinya | |||
| Sandra Margielewska | |||
| Wenbin Wi | |||
| P2860 | cites work | Role of the tumor microenvironment in mature B-cell lymphoid malignancies | Q26748775 |
| The tumor microenvironment shapes hallmarks of mature B-cell malignancies | Q27687567 | ||
| The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies | Q29614311 | ||
| Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point | Q30234455 | ||
| The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation | Q33707429 | ||
| Tumor-associated macrophages and survival in classic Hodgkin's lymphoma | Q33962334 | ||
| The effect of Epstein-Barr virus Latent Membrane Protein 2 expression on the kinetics of early B cell infection | Q34545445 | ||
| Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses | Q34650346 | ||
| Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
| Oncogenic properties of apoptotic tumor cells in aggressive B cell lymphoma | Q35565000 | ||
| Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells | Q35661383 | ||
| Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma | Q35808018 | ||
| Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease | Q36201443 | ||
| Immune Evasion by B-cell Lymphoma | Q36541271 | ||
| PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma | Q37340738 | ||
| Role of tumor microenvironment in tumorigenesis | Q37738074 | ||
| The tumour microenvironment in B cell lymphomas | Q38227748 | ||
| Epstein-Barr virus and Burkitt lymphoma. | Q38270680 | ||
| Cross-talk between Epstein-Barr virus and microenvironment in the pathogenesis of lymphomas | Q38466246 | ||
| Epstein-Barr virus latent membrane protein 2A mediated activation of Sonic Hedgehog pathway induces HLA class Ia downregulation in gastric cancer cells | Q38865839 | ||
| Clinical significance of CD163⁺ tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma | Q39171301 | ||
| Intimate cross-talk between cancer cells and the tumor microenvironment of B-cell lymphomas: The key role of exosomes | Q39376074 | ||
| Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes. | Q39606098 | ||
| Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial. | Q39849626 | ||
| Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer | Q40241719 | ||
| PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies | Q41826795 | ||
| Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues | Q42657345 | ||
| CD80 Expressed by CD8+ T Cells Contributes to PD-L1-Induced Apoptosis of Activated CD8+ T Cells. | Q45204023 | ||
| Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues | Q46308773 | ||
| Posttranscriptional Control of PD-L1 Expression by 17β-Estradiol via PI3K/Akt Signaling Pathway in ERα-Positive Cancer Cell Lines. | Q49214132 | ||
| Profiling Tumor Infiltrating Immune Cells with CIBERSORT. | Q49979363 | ||
| EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts. | Q51735191 | ||
| Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma. | Q52718325 | ||
| IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling. | Q52727974 | ||
| The Microenvironment in Epstein-Barr Virus-Associated Malignancies. | Q54236409 | ||
| The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas. | Q54957513 | ||
| How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa | Q62490169 | ||
| Role of Epstein Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature | Q63633910 | ||
| Interaction of tumor-associated macrophages and cancer chemotherapy | Q64268061 | ||
| Microenvironment Cell Contribution to Lymphoma Immunity. | Q64997020 | ||
| Human herpesvirus 8 (HHV-8) inhibits monocyte differentiation into dendritic cells and impairs their immunostimulatory activity | Q81151816 | ||
| An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone | Q87047382 | ||
| Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count | Q91149197 | ||
| Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application | Q91519832 | ||
| Advanced Burkitt Lymphoma in Sub-Saharan Africa Pediatric Units: Results of the Third Prospective Multicenter Study of the Groupe Franco-Africain d'Oncologie Pédiatrique | Q91636476 | ||
| Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates - A multicenter cohort study | Q92175047 | ||
| Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus | Q92238951 | ||
| Targeting immune cells for cancer therapy | Q92656858 | ||
| P2507 | corrigendum / erratum | Correction to: Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program | Q96303787 |
| P921 | main subject | Burkitt lymphoma | Q1016605 |
| P304 | page(s) | 28 | |
| P577 | publication date | 2020-05-06 | |
| P1433 | published in | Infectious Agents and Cancer | Q15814259 |
| P1476 | title | Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program | |
| P478 | volume | 15 |
Search more.